AQST - Aquestive Therapeutics Inc Qarzning balans kapitallashuviga nisbati

Aquestive Therapeutics Inc (AQST) grafik logotipi

Aquestive Therapeutics (AQST) qat'iy FDA nazorati ostida faoliyat yuritayotgan bir paytda, o'zining innovatsion PharmFilm dori yetkazib berish tizimi uchun patentlar bilan himoyalangan. Biznesning ekologik yo'nalishi yupqa plyonkalardan foydalanish orqali plastikni kamaytirishga asoslangan. Kompaniyaning bozor qiymati vizualizatsiyasi 0.00 darajasida turibdi. Korxona hozirda transport uzilishlarini bartaraf etish va ishlab chiqarish hajmini barqarorlashtirish uchun mintaqaviy hamkorlar bilan aloqa o'rnatgan holda xomashyo ta'minoti zanjirlarini optimallashtirmoqda.

AQST (Aquestive Corp) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

Aquestive Therapeutics Inc (AQST) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Aquestive Therapeutics|AQST - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Aquestive Corp|AQST - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Aquestive Therapeutics|AQST - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati aquestive.com|AQST - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Aquestive Therapeutics|AQST - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Aquestive Pharma|AQST - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Aquestive Corp|AQST - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Aquestive Therapeutics
Kompaniyaning barcha koʻrsatkichlari tahlili:AQST Aquestive Therapeutics
Aquestive Pharma asosiy tovari

Ushbu ko'rsatkich biznesning qarz mablag'lariga nisbatan kapitalga bo'lgan bog'liqlik darajasini o'lchab, Aquestive Therapeutics (AQST) kompaniyasining moliyaviy zarbalarga nisbatan zaifligini va majburiyatlar xizmatini ko'rsatish xarajatlarini aniqlaydi. Barqaror moliyaviy tuzilma — qarzning kitob kapitalizatsiyasiga nisbati — noyob tez ta'sir qiluvchi dori tizimini ishlab chiqish uchun resurs bazasini tasdiqlaydi va investorga kompaniyaning qarz yuklamasi hamda uning investitsiya salohiyati o'rtasidagi muvozanatni baholash imkonini beradi.

Aquestive Therapeutics raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati sxtchina.com (SXTC)|Balans kapitallashuviga qarzlar EPRX (Eupraxia Pharmaceuticals Inc.)|BioHarvest Sciences, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati EXOZ|Oramed Pharmaceuticals (ORMP) - Qarzning sof aktivlarga nisbati|ENTX: Qarzning balans qiymatiga nisbati|ipatherapeutics.com (HYFT) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ABVC (ABVC BioPharma, Inc.)|Balans qiymatiga qarzlar CPIX|QNTM (Quantum BioPharma Limited) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar FibroGen Corporation FGEN|Qarzning balans qiymatiga nisbati Telomir Pharmaceuticals (TELO)|Qarzning balans kapitaliga nisbati Rani Therapeutics Holdings RANI|Balans kapitallashuviga qarzlar SNYR (Synergy CHC Corporation)|Rallybio Corporation (RLYB) - Sof aktivlarga qarzlar|lexariabioscience.com (LEXX) - Qarzning balans qiymatiga nisbati|Pulmatrix Corporation (PULM) - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar PTHL (Pheton Holdings Limited)|Balans qiymatiga qarzlar Aptorum (APM)|Lyra Therapeutics (LYRA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Impact BioMedical, Inc. IBO|Qarzning balans qiymatiga nisbati TNF Pharmaceuticals, Inc. (TNFA)|Qarzning balans kapitaliga nisbati cbdMD Inc. YCBD|Balans kapitallashuviga qarzlar PainReform Ltd. (PRFX)|CYTO - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar LIPO|OPTN (OptiNose Inc) - Balans qiymatiga qarzlar|PIRS - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Procaps Group Corp|Balans kapitallashuviga qarzlar PTPI|Balans kapitallashuviga qarzlar QLI (qlsyy.net)|ACELYRIN (SLRN) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati TFF Pharmaceuticals Inc. TFFP